Health & Pharma
The Client:
A publicly listed pharmaceutical manufacturer evaluating expansion into industrial automation, robotics, and diagnostic technology.
The Challenge:
A publicly listed pharmaceutical manufacturer evaluating expansion into industrial automation, robotics, and diagnostic technology.
The Challenge:
A publicly listed pharmaceutical manufacturer evaluating expansion into industrial automation, robotics, and diagnostic technology.
The Challenge: The client needed to evaluate manufacturing automation, healthcare-adjacent robotics, and diagnostic equipment across a wide and unfamiliar Chinese supplier landscape.
The standard approach - trade fairs, generic supplier directories, third-party introductions - generates conversations, not decisions. Leadership time in China is finite and expensive; the engagement needed to convert every hour on the ground into procurement-grade intelligence.
The Challenge:
What We Did:
-
Designed a bespoke multi-day, multi-cluster China factory visit programme organized around the client's product priorities
-
Pre-qualified every factory across dimensions - technical capability, certifications held, India compliance pathway, commercial readiness, export experience, and leadership engagement - each scored and tiered
-
Secured director-level meetings at every factory, bypassing sales-floor presentations
-
Pre-mapped India import compliance for every product category before departure - regulatory pathway, applicable duty structure, and import restriction risk
-
Delivered structured pre-visit briefing notes per factory and managed all on-the-ground logistics, translation, and scheduling
The Impact:
40+ hrs
Logistics Savings
Condensed a massive supplier landscape into intensive, high-yield meetings, cutting out weeks of standard supplier sourcing.
Top 3
Tiered Per Category
Vetting - Pre-scored dozens of candidate facilities across strict technical capability and compliance dimensions prior to departure.
12
Day Turnaround
Post-Trip Execution - Delivered a full technical evaluation and localized roadmap within two weeks of landing back in India.